Clinicopathological and Molecular Characteristics of PIK3CA-mutant Gastric Cancer with Emphasis on its Tumor Immune Microenvironment

被引：0
|
作者：
Choi, Sangjoon [1 ]
Kim, Hyunjin [1 ]
Kang, Won Ki [1 ]
Kim, Kyoung-Mee [1 ]
机构：
[1] Samsung Med Ctr, Seoul, South Korea
来源：
MODERN PATHOLOGY | 2022年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
401
引用
收藏
页码：436 / 438
页数：3
相关论文
共 50 条
  • [1] Clinicopathological and Molecular Characteristics of PIK3CA-mutant Gastric Cancer with Emphasis on its Tumor Immune Microenvironment
    Choi, Sangjoon
    Kim, Hyunjin
    Kang, Won Ki
    Kim, Kyoung-Mee
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 436 - 438
  • [2] Clinicopathological and Molecular Characteristics of PIK3CA-mutant Gastric Cancer with Emphasis on its Tumor Immune Microenvironment
    Choi, Sangjoon
    Kim, Hyunjin
    Kang, Won Ki
    Kim, Kyoung-Mee
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 436 - 438
  • [3] Fisetin for the management of PIK3CA-mutant colorectal cancer
    Khan, Naghma
    Jajeh, Farah
    Miller, Devon
    Van Doorn, Rachel
    Eberhardt, Emily Lauren
    Halberg, Richard B.
    Mukhtar, Hasan
    CANCER RESEARCH, 2018, 78 (13)
  • [4] Alpelisib Extends PFS in PIK3CA-Mutant Breast Cancer
    Dolgin, Elie
    CANCER DISCOVERY, 2019, 9 (01) : 6 - 7
  • [5] Clinicopathological and Molecular Correlates of PIK3CA Mutations in Gastric Cancer
    Sukawa, Yasutaka
    Yamamoto, Hiroyuki
    Nosho, Katsuhiko
    Adachi, Yasushi
    Kunimoto, Hiroaki
    Igarashi, Hisayoshi
    Nakazawa, Mayumi
    Suzuki, Hiromu
    Sasaki, Shigeru
    Shinomura, Yasuhisa
    GASTROENTEROLOGY, 2012, 142 (05) : S322 - S322
  • [6] Targeting PIK3CA-mutant advanced breast cancer in the clinical setting
    Chopra, Neha
    Turner, Nicholas C.
    LANCET ONCOLOGY, 2017, 18 (07): : 842 - 843
  • [7] Fisetin, a dietary flavonoid for the prevention and treatment of PIK3CA-mutant colorectal cancer
    Khan, Naghma
    Jajeh, Farah
    Miller, Devon
    Van Doorn, Rachel
    Halberg, Richard B.
    Mukhtar, Hasan
    CANCER RESEARCH, 2017, 77
  • [8] Response of Brain Metastases From PIK3CA-Mutant Breast Cancer to Alpelisib
    Batalini, Felipe
    Moulder, Stacy L.
    Winer, Eric P.
    Rugo, Hope S.
    Lin, Nancy U.
    Wulf, Gerburg M.
    JCO PRECISION ONCOLOGY, 2020, 4 : 572 - 578
  • [9] Fisetin and 5-fluorouracil: Effective combination for PIK3CA-mutant colorectal cancer
    Khan, Naghma
    Jajeh, Farah
    Eberhardt, Emily L.
    Miller, Devon D.
    Albrecht, Dawn M.
    Van Doorn, Rachel
    Hruby, Melissa D.
    Maresh, Morgan E.
    Clipson, Linda
    Mukhtar, Hasan
    Halberg, Richard B.
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (11) : 3022 - 3032
  • [10] Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells
    Gu, Mancang
    Nishihara, Reiko
    Chen, Yang
    Li, Wanwan
    Shi, Yan
    Masugi, Yohei
    Hamada, Tsuyoshi
    Kosumi, Keisuke
    Liu, Li
    da Silva, Annacarolina
    Nowak, Jonathan A.
    Twombly, Tyler
    Du, Chunxia
    Koh, Hideo
    Li, Wenbin
    Meyerhardt, Jeffrey A.
    Wolpin, Brian M.
    Giannakis, Marios
    Aguirre, Andrew J.
    Bass, Adam J.
    Drew, David A.
    Chan, Andrew T.
    Fuchs, Charles S.
    Qian, Zhi Rong
    Ogino, Shuji
    ONCOTARGET, 2017, 8 (50) : 87379 - 87389
12345